Key result
Obesity is a principal contributing factor to the risk of venous thromboembolism in pregnancy, necessitating targeted approaches for prophylaxis, diagnosis, and management.
This review highlights the increased risk of VTE in obese pregnant women and provides guidance on prophylaxis, diagnosis, and management using LMWH.
Answers are grounded in this paper and cite their sources.
May warrant enhanced VTE prophylaxis in obese pregnancies; leaves open optimal strategies pending prospective validation.
Venous thromboembolism (VTE) remains among the leading causes of maternal mortality in the developed world, presenting variably as deep vein thrombosis (DVT), pulmonary embolism (PE) or cerebral vein thrombosis (CVT), among others. Obesity in particular has been recognized as the principal contributing factor to the risk of VTE in pregnancy and with the global increase in the rates of obesity affecting reproductive age women, heightened awareness of the risk and consequences of VTE in this population are vital. Thus, prophylaxis, diagnosis and treatment of VTE in the obese gravida are discussed.
No takes yet. Share an insight, caveat, or question.
Malinowski et al. (2017) conducted a review in Venous thromboembolism in obese pregnant women. Venous thromboembolism prophylaxis and management was evaluated. Obesity is a principal contributing factor to the risk of venous thromboembolism in pregnancy, necessitating targeted approaches for prophylaxis, diagnosis, and management.
Synapse has enriched 10 related papers. Consider them for comparative context: